SOTAC PHARMACEUTICALS LTD Share Price

₹ 122.85

+₹5.85 (5.00%)
1D
Last updated 03 Nov, 2026, 09:15 IST
NSE: SOTAC
|
Pharmaceuticals

SOTAC PHARMACEUTICALS LTD Share Price Today

As of 3 Nov 2026, SOTAC PHARMACEUTICALS LTD share price is ₹122.85. The stock opened at ₹122.85, compared to its previous close of ₹117.00. During today's trading session, SOTAC PHARMACEUTICALS LTD share price moved in the range of ₹122.85 to ₹122.85, with an average price of ₹122.85 for the day. Looking at its last 52-week, the stock has touched a low of ₹86.00 and a high of ₹139.65. On the performance front, SOTAC PHARMACEUTICALS LTD share price has increased by 5.26% over the last six months and is down 9.30% on a year-on-year basis.

Share price over the last 1 day rose from 122.85 to 122.85, ranging between 122.85 and 122.85.
₹122.85
5.00% up today
₹122.85
1D LOW
1D HIGH

SOTAC PHARMACEUTICALS LTD Stock Insights

Latest Earning
Op Profit TrendUp by 333.33% QoQ
Latest Earning
Net Profit TrendDown by 10.60% QoQ
Latest Earning
Revenue TrendUp by 0.69% YoY
Stock Performance
OutperformingBeat Nifty by 22.08 % in last 1 month
Shareholding Pattern
FIIFII decreased stake by 1.94%
SOTAC PHARMACEUTICALS LTD stock performance
Open₹122.85
High₹122.85
Low₹122.85
Prev. close₹117.00
SOTAC PHARMACEUTICALS LTD trading activity
Volume1,200
Average traded price₹122.85
Last traded time09:15:21 03 Nov
Last traded quantity1,200
Circuit
L
H
₹111.15
₹122.85
52-week
L
H
₹86.00
₹139.65
Mkt Cap Cr
129.29
P/E
20.93
P/B
2.05
ROA
5.64%
ROE
11.22%
ROCE
13.23%
Quick Ratio
0.87
EV/EBITDA
8.62

Based on fundamentals, this stock's

Performance: 5 out of 5, Excellent
Performance
Excellent
Sotac Pharma. outperforming all market indices
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Sotac Pharma. appears overvalued compared to its peers
Earnings: 3 out of 5, Neutral
Earnings
Neutral
Sotac Pharma. earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,24,202.4238.614.759.61%13.79%18.65%2.3122.27
Divis Laboratories2,57,902.7390.3115.7614.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,74,402.4783.099.494.7%11.42%11.37%0.7533.6
Laurus Labs1,26,811.2895.1720.9211.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,24,089.4826.934.568.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,11,868.0340.542.884.79%7.21%8.58%1.3519.05
Cipla1,11,647.7239.123.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,195.6245.155.817.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,536.9026.132.566.34%9.25%11.76%1.1512.38
Lupin91,870.1616.454.0714.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

SOTAC PHARMACEUTICALS LTD Company Background

ISIN
INE0O2D01012
Sector Market Cap
₹ 129.29 Cr

Sotac Pharmaceuticals Limited is an India-based pharmaceutical company. The Company's services include contract manufacturing, loan license, formulation and development (F & D) and research and development (R & D). It specializes in manufacturing a range of pharmaceutical products having a therapeutic portfolio including anti-diabetic, anti-psychotic, vitamins, minerals, iron, anti-cold, anti-allergic, dermatological products, antacid, anti-ulcerants, PPI, anti-emetics, cardiac, anti-hypertensives, analgesic, anti-pyretic, anti-inflammatory, anti-bacterial, anti-viral, general antibiotics (IP-Lactams & Non-IP-Lactams), anti-fungal and cephalosporin. It also manufactures nutraceuticals products and food products on contract-manufacturing basis. Its products are supplied across 14 states in India, and it exports its products to over 20 countries worldwide. Its subsidiaries include Sotac Healthcare Private Limited, Sotac Lifesciences Private Limited and Sotac Research Private Limited.

SOTAC PHARMACEUTICALS LTD Financial Highlights

  • Revenue: SOTAC PHARMACEUTICALS LTD reported revenue of ₹101.59 crore in FY26 vs ₹100.89 crore in FY25. It showed an increase of 0.69% on a yearly basis.
  • Operating Profit: SOTAC PHARMACEUTICALS LTD reported an operating profit of ₹8.70 crore in FY26 vs ₹11.12 crore in FY25. It showed a decrease of 21.76% on a year-on-year basis.
  • Net Profit: SOTAC PHARMACEUTICALS LTD reported a net profit of ₹6.29 crore in FY26 vs ₹9.28 crore in FY25. It showed a decrease of 32.22% on a yearly basis.

SOTAC PHARMACEUTICALS LTD Quarterly Result Highlights

  • SOTAC PHARMACEUTICALS LTD reported revenue of ₹25.50 crore in Jun 2024, compared with ₹26.80 crore in Mar 2024, representing a decrease of 4.85% on a quarter-on-quarter (QoQ) basis.
  • SOTAC PHARMACEUTICALS LTD reported an operating profit of ₹1.30 crore in Jun 2024, compared with ₹0.30 crore in Mar 2024, representing an increase of 333.33% on a quarter-on-quarter (QoQ) basis.
  • SOTAC PHARMACEUTICALS LTD reported a profit of ₹1.35 crore in Jun 2024, compared with ₹1.51 crore in Mar 2024, reflecting a decrease of 10.60% on a QoQ basis.
  • The earnings per share (EPS) of SOTAC PHARMACEUTICALS LTD stood at ₹5.22 during Jun 2024.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
72.85%
FII
16.46%
Other DII
0.00%
Retail and other
10.69%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Mar 202515.12%
Sep 202516.14%
Mar 202616.79%
Sep 202616.46%

SOTAC PHARMACEUTICALS LTD Investment Returns

1 day
+4.79%
1 week
+21.24%
1 month
+29.93%
1 year
-9.30%
3 years
-6.40%
5 years
-3.11%

SOTAC PHARMACEUTICALS LTD Share Price History

SOTAC PHARMACEUTICALS LTD share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
02 Nov 26
₹117.20 / ₹117.00
+4.79%
30 Oct 26
₹111.65 / ₹111.65
+4.98%
29 Oct 26
₹106.35 / ₹106.35
+4.99%
28 Oct 26
₹101.25 / ₹101.30
+4.97%
Show more

SOTAC PHARMACEUTICALS LTD Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹101.24₹96.99₹103.83₹77.48
Other Income₹0.35₹3.90₹0.49₹0.35
Total Revenue₹101.59₹100.88₹104.32₹77.83
Total Expenses₹92.89₹89.76₹100.12₹74.49
Profit Before Tax₹8.70₹11.12₹3.96₹3.93
Tax₹2.40₹1.84₹0.38₹1.64
Profit After Tax₹6.29₹9.28₹3.58₹2.29
EPS - Basic₹5.22₹7.26₹3.90₹3.58
EPS - Diluted₹5.22₹7.26₹3.90₹3.58

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹8.70₹11.12₹3.96₹3.93
Income before WC changes₹18.08₹17.38₹6.32₹8.25
Change in Assets-₹8.24-₹11.04-₹19.77₹3.69
Change in Liabilities₹9.09-₹9.89-₹0.94-₹2.12
Change in WC₹0.86-₹20.93-₹20.71₹1.57
Cash flow from Operations₹16.85-₹4.35-₹16.08₹8.14
Cash flow from Investing-₹6.90-₹13.62-₹19.68-₹11.67
Cash flow from Financing-₹10.34₹16.11₹29.49₹13.14
Total Cash Flow-₹0.39-₹1.85-₹6.26₹9.61
Cash (Start of the year)₹1.56₹3.42₹9.68₹0.08
Cash (End of the year)₹1.18₹1.56₹3.42₹9.68

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹55.79₹54.50₹44.68₹26.50
Current Assets₹77.68₹69.83₹60.65₹47.14
Total Assets₹133.47₹124.33₹105.33₹73.64
Current Liabilities₹58.36₹51.55₹43.73₹45.81
Net Current Asset₹19.32₹18.28₹16.92₹1.33
Non-Current Liabilities₹10.54₹14.36₹12.27₹8.14
Equity Capital₹64.57₹58.42₹49.33₹19.69
Total Equity & Liabilities₹133.47₹124.33₹105.33₹73.64

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹71.88₹62.38₹67.11₹57.98
Other Income₹2.10₹2.38₹1.32₹0.24
Total Revenue₹73.98₹64.76₹68.42₹58.23
Total Expenses₹67.05₹58.34₹60.43₹52.26
Profit Before Tax₹6.92₹6.41₹7.76₹5.96
Tax₹2.01₹1.64₹2.01₹1.47
Profit After Tax₹4.92₹4.77₹5.75₹4.50
EPS - Basic₹4.45₹4.32₹5.24₹5.58
EPS - Diluted₹4.45₹4.32₹5.24₹5.58

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹6.92₹6.41₹7.76₹5.96
Income before WC changes₹9.20₹8.50₹7.97₹8.35
Change in Assets-₹7.63-₹8.35-₹19.10₹0.47
Change in Liabilities₹12.46-₹5.45-₹6.93₹1.41
Change in WC₹4.83-₹13.79-₹26.02₹1.87
Cash flow from Operations₹12.14-₹6.10-₹19.75₹8.54
Cash flow from Investing-₹2.30-₹1.89-₹12.53-₹10.93
Cash flow from Financing-₹9.94₹7.79₹23.32₹11.97
Total Cash Flow-₹0.11-₹0.20-₹8.96₹9.57
Cash (Start of the year)₹0.45₹0.64₹9.60₹0.03
Cash (End of the year)₹0.34₹0.45₹0.64₹9.60

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹32.19₹30.40₹29.34₹18.18
Current Assets₹62.42₹54.90₹46.75₹36.61
Total Assets₹94.61₹85.29₹76.09₹54.78
Current Liabilities₹35.13₹26.49₹23.28₹27.11
Net Current Asset₹27.29₹28.40₹23.47₹9.49
Non-Current Liabilities₹1.66₹5.77₹4.53₹6.68
Equity Capital₹57.82₹53.03₹48.27₹20.99
Total Equity & Liabilities₹94.61₹85.29₹76.09₹54.78
* All values are in INR Crore
SOTAC PHARMACEUTICALS LTD market depth
Bid quantityBid priceAsk priceAsk quantity
0000
0000
0000
0000
0000
Total bid quantity0
Total ask quantity0
SOTAC PHARMACEUTICALS LTD technical summary
Bearish indicators5
Neutral indicators1
Bullish indicators2
OverallSlightly Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
71.01
Bullish
ATR (14)
3.85
Neutral
STOCH(9,6)
99.33
Bearish
STOCH RSI (14)
100
Bearish
ADX(9)
40.85
Bearish
UO(9)
83.59
Bearish
ROC(12)
17
Bullish
WillR(14)
-0.64
Bearish
Period
Simple value
Exponential vaue
5D
106.56
107.96
10D
98.43
103.22
20D
99.94
101.97
50D
106.08
102.25
100D
112.8
0
Volume trend — traded volume by day
3 Nov0L
2 Nov0L
30 Oct0L
29 Oct0L
28 Oct0L
27 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

SOTAC PHARMACEUTICALS LTD
Pharmaceuticals
Add Stock
Add Another

SOTAC PHARMACEUTICALS LTD Returns Calculator

Ex-date: 23 Sep 2026

Top Gainers

KRBL Share Price
₹401.45
+38.45 (+10.59%)
MARICO Share Price
₹878.40
+79.85 (+10%)
BALRAMCHIN Share Price
₹654.80
+54.9 (+9.15%)
TRIDENT Share Price
₹23.79
+1.58 (+7.11%)
AEGISLOG Share Price
₹1177.10
+77 (+7%)
See more

Top Losers

KEC Share Price
₹316.35
-32.65 (-9.36%)
GNFC Share Price
₹465.05
-45.95 (-8.99%)
PRAJIND Share Price
₹254.63
-16.5 (-6.09%)
AIAENG Share Price
₹3389.70
-217.6 (-6.03%)
GESHIP Share Price
₹1536.50
-63.9 (-3.99%)
See more

SOTAC PHARMACEUTICALS LTD Share Price FAQs

Please be aware that SOTAC PHARMACEUTICALS LTD stock prices are subject to continuous fluctuations due to various factors.